SUBSTITUTED QUINOLINES AND THEIR USE AS MYCOBACTERIAL INHIBITORS
The present invention relates to novel substituted quinoline derivatives according to the general formula (Ia) or the general formula (Ib) salts, quaternary amines, stereochemically isomeric forms, tautomeric forms and N~- oxide forms thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
04.08.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to novel substituted quinoline derivatives according to the general formula (Ia) or the general formula (Ib) salts, quaternary amines, stereochemically isomeric forms, tautomeric forms and N~- oxide forms thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy , Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl ; p is 1, 2, 3 or 4 ; R2 is hydrogen, hydroxy, thio, alkyloxy , alkyloxyalkyloxy, alkylthio, mono or di(alkyl)amino or a radical of formula (Ic);R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; R4 is hydrogen, alkyl or benzyl; R5 is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl ; or two vicinal R5 radicals may be taken together to form together with the phenyl ring to which they are attached a naphthyl; r is 1, 2, 3, 4 or 5 ; R6 is hydrogen, alkyl, Ar or Het R7 is hydrogen or alkyl; R8 is oxo ; or R7 and R8 taken together form the radical - CH=CH-N=; Z is CH2 or C(=O). The claimed compounds are useful for the treatment of mycobacterial diseases, particular ly those diseases caused by pathogenic mycobacteria such as M. tuberculosis, M. bovis, M. avium, M. smegmatis and M. marinum. Also claimed is a pharmaceutic al composition containinga compound of the present invention, the use of the claimed compounds or compositions for the manufacture of a medicament for th e treatment of mycobacterial diseases and a process for preparing the claimed compounds. |
---|---|
AbstractList | The present invention relates to novel substituted quinoline derivatives according to the general formula (Ia) or the general formula (Ib) salts, quaternary amines, stereochemically isomeric forms, tautomeric forms and N~- oxide forms thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy , Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl ; p is 1, 2, 3 or 4 ; R2 is hydrogen, hydroxy, thio, alkyloxy , alkyloxyalkyloxy, alkylthio, mono or di(alkyl)amino or a radical of formula (Ic);R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; R4 is hydrogen, alkyl or benzyl; R5 is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl ; or two vicinal R5 radicals may be taken together to form together with the phenyl ring to which they are attached a naphthyl; r is 1, 2, 3, 4 or 5 ; R6 is hydrogen, alkyl, Ar or Het R7 is hydrogen or alkyl; R8 is oxo ; or R7 and R8 taken together form the radical - CH=CH-N=; Z is CH2 or C(=O). The claimed compounds are useful for the treatment of mycobacterial diseases, particular ly those diseases caused by pathogenic mycobacteria such as M. tuberculosis, M. bovis, M. avium, M. smegmatis and M. marinum. Also claimed is a pharmaceutic al composition containinga compound of the present invention, the use of the claimed compounds or compositions for the manufacture of a medicament for th e treatment of mycobacterial diseases and a process for preparing the claimed compounds. |
Author | GUILLEMONT, JEROME EMILE GEORGES PASQUIER, ELISABETH THERESE JEANNE |
Author_xml | – fullname: GUILLEMONT, JEROME EMILE GEORGES – fullname: PASQUIER, ELISABETH THERESE JEANNE |
BookMark | eNrjYmDJy89L5WRwCA51Cg7xDAkNcXVRCAz19PP38fRzDVZw9HNRCPFw9QxSCA12VXAMVvCNdPZ3cnQOcQ3ydPRR8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjkampsZGZmaOhsZEKAEAkW4sNg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | QUINOLINES SUBSTITUEES ET LEUR UTILISATION COMME INHIBITEURSMYCOBACTERIENS |
ExternalDocumentID | CA2553266A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2553266A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:18:52 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2553266A13 |
Notes | Application Number: CA20052553266 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050804&DB=EPODOC&CC=CA&NR=2553266A1 |
ParticipantIDs | epo_espacenet_CA2553266A1 |
PublicationCentury | 2000 |
PublicationDate | 20050804 |
PublicationDateYYYYMMDD | 2005-08-04 |
PublicationDate_xml | – month: 08 year: 2005 text: 20050804 day: 04 |
PublicationDecade | 2000 |
PublicationYear | 2005 |
RelatedCompanies | JANSSEN PHARMACEUTICA, N.V |
RelatedCompanies_xml | – name: JANSSEN PHARMACEUTICA, N.V |
Score | 2.6293502 |
Snippet | The present invention relates to novel substituted quinoline derivatives according to the general formula (Ia) or the general formula (Ib) salts, quaternary... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | SUBSTITUTED QUINOLINES AND THEIR USE AS MYCOBACTERIAL INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050804&DB=EPODOC&locale=&CC=CA&NR=2553266A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IP0Fnwk3baHIJtNQlbapDaJ1FPJpgn0khYb8e87u7TVi96WXRj2wez37WO-AbizHkxJTfloKDg2rKKcGwMEBqPsPuU9pElZoV_PRyENUutl2p02YLGNhdE6oV9aHBE9Kkd_r_V-vfq5xHL138r1vVxg1fLZT2y3sz0dI93ARXcd2xtHbsQ7nNucdcKJjcwZiQpleFDaUyxayex7b44KSln9RhT_GPbHaKyqT6BRVC045NvEay04GG3eu7G4cb31qYq0cuJEJCluNeQ1FWE0VAkzCAtdkgSemJA09giLyeidRw7jSFMFGxIRBsIRSTSJz4D4XsIDA7sy2w17xtmu0-Y5NKtlVVwAofNBL89MBdU9q5R5hnwNSVTWl7SkOZVtaP9p5vKftis40qqk6jeEdQ3N-uOzuEG8reWtnqlvLNh-Uw |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8IGvGmqBE_ezDcFj82OjksputGVmUbss7giaxjS7gMIjP--742gF701rRJ89rmvd_v9fW9InRj3ZmSmPLeUHBsWEU5M_oADEbZe8htoElZoaPnYUSC1Hqe9CYNNN_kwug6oV-6OCJoVA76Xmt7vfy5xPL028rVrZxD1-JpIByvu_GOgW7AoXuu449iL2ZdxhxGu9HYAeYMRIVQcJR2bPAIVZl9_81VSSnL34gyOEC7I5isqg9Ro6jaqMU2H6-10V64jndDc616qyOVaeUmgosUTA1-TXkUD9WHGZhGHhaBz8c4TXxMExy-s9ilDGgqp0PMo4C7XMTj5BjhgS9YYIAo0-2yp4xuhTZPULNaVMUpwmTWt_PMVFBtW6XMM-BrQKKyR0lKkhPZQZ0_pzn7Z-watQIRDqcg-8s52tcVStXLCOsCNeuPz-ISsLeWV3rXvgE7C4E- |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SUBSTITUTED+QUINOLINES+AND+THEIR+USE+AS+MYCOBACTERIAL+INHIBITORS&rft.inventor=GUILLEMONT%2C+JEROME+EMILE+GEORGES&rft.inventor=PASQUIER%2C+ELISABETH+THERESE+JEANNE&rft.date=2005-08-04&rft.externalDBID=A1&rft.externalDocID=CA2553266A1 |